What's new?

Sofinnova Partners Announces Sale of Corvidia Therapeutics to Novo Nordisk

Novo Nordisk acquires Corvidia for $2.1B with an upfront payment of $725M in cash   Sofinnova Partners co-founded Corvidia as its sole seed financial investor in 2015 with serial entrepreneur Michael Davidson   PARIS, France – June 11, 2020 - Sofinnova Partners, a leading European life sciences venture capital firm...

Comet Bio Wins “Start-Up of the Year” NutraIngredients Award for 2020

SCHAUMBURG, Ill., July 14, 2020 /PRNewswire/ – Comet Bio, a manufacturer of healthy, sustainable, and award-winning ingredients, announced today it has been named the winner of this year’s NutraIngredients USA Start-Up of the Year award.  This award recognizes the company’s unique line of innovative ingredients and...

Venus Medtech to Partner with Pi-Cardia to Bring its Leaflex(TM) Aortic Valve Technology to China

Jul 14, 2020, 06:11 ET HANGZHOU, China and REHOVOT, Israel, July 14, 2020 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (stock code: 2500.HK), the leading transcatheter heart valve medical device player in China, and Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for trea...

Inventiva announces the pricing of its initial public offering on the Nasdaq Global Market

Daix (France), July 10, 2020 – INVENTIVA S.A. (Euronext Paris: IVA) (“Inventiva” or the “Company”), a clinical- stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (“NASH”), mucopolysaccharidoses (“MPS”) and other diseases wi...

Biotalys appoints Wim Ottevaere as Chief Financial Officer in preparation for global growth

Strengthening Executive Management Team with international financial leadership   July 09, 2020 02:00 ET | Source: Biotalys   GHENT, Belgium and RESEARCH TRIANGLE PARK, N.C., July 09, 2020 (GLOBE NEWSWIRE) -- Biotalys NV, a transformative food and crop protection company, today announced the appointment of Wim Otte...

RefleXion and Telix Pharmaceuticals Announce Strategic Collaboration for Treatment of High-Risk Cancers

July 08, 2020 10:00 AM Eastern Daylight Time     HAYWARD, Calif. & MELBOURNE, Australia--(BUSINESS WIRE)--RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, and Telix Pharmaceuticals Limited (ASX: TLX), a radiopharmac...

Success of the capital increase with pre-emptive subscription rights: €7.3 million raised to finance the Prima System PRIMAvera pivotal study

Success of the capital increase with pre-emptive subscription rights: €7.3 million raised to finance the Prima System PRIMAvera pivotal study                       Paris, 6 July 2020 – 7.00 a.m. CET - Pixium Vision (Euronext Growth Paris - FR0011950641 - ALPIX) (“Pixium Vision” or the “Company”), a company that dev...

Sensorion appoints Dr Edwin Moses, former Ablynx CEO, as Chairman of the Board

- Dr Moses is internationally recognized as a leading CEO and Chairman of life science companies - Dr Moses led the rapid growth of Ablynx from a platform technology to a fully integrated biopharmaceutical company prior its acquisition by Sanofi - Appointment adds momentum and validation to Sensorion assets and str...

MastOR secures seed funding from Sofinnova Partners to develop its laparoscopy assistance platform

PARIS, FRANCE / ACCESSWIRE / July 2, 2020 -- MastOR, a medical device company developing a surgical robot for laparoscopy assistance, announced today a €3M equity round through a seed investment from the Sofinnova Partners MD Start III Fund, as well as an additional €1.9M in non-dilutive funding through the i-Nov I...

Redx Pharma: Proposed financing of $30 million via issue of convertible loan notes and share subscription and notice of General Meeting

DJ Redx Pharma plc Proposed financing of $30m and notice of GM   TIDMREDX RNS Number : 4498R Redx Pharma plc 30 June 2020 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULA TION (596/2014). UPON THE PUBLICATION ...

ELSAN partners with Sofinnova MD Start III, an acceleration fund dedicated to healthcare innovation and medical devices

This collaboration aims to enable ELSAN physicians to transform their ideas for innovation into clinically-validated devices and to contribute their expertise to new projects. June 25, 2020 - PARIS, France - ELSAN, a leader in the private hospital sector in France, announces a strategic partnership with the Sofinno...

1 2 3 4